Spain has received this Tuesday the first 5,300 doses of the Jynneos vaccine against Monkeypox or monkeypox. The vaccines are part of the purchase carried out by the European Commission through the Health Emergency Preparedness and Response Authority (HERA).
This European initiative has allowed member states to have third-generation vaccines against this disease in an equitable manner based on epidemiological and demographic criteria. Two more shipments are expected in the coming months. The contract signed by HERA made it possible to acquire 110,000 doses for the entire European Union and Spain will receive 10 percent, which places us as the European country with the highest receipt of vaccines against Monkeypox.
Vaccines must be stored deep-frozen to ensure their quality, safety, and efficacy and are made available to public health authorities for control of this outbreak.
These vaccines are added to the 200 doses of INVAMEX that Spain bought from a neighboring country and that are already being inoculated at the request of the Autonomous Communities, following the protocol approved by the Public Health Commission, hand in hand with the Vaccine Report.
In Spain, as of June 28, a total of 1,158 confirmed cases of Monkeypox have been reported, including 773 in Madrid.
- Polio vaccination campaign launched to vaccinate 12.6 million children across Pakistan
- Second monkeypox cases reported in South Africa
- Philippines dengue: North Cotabato reports 390% increase in cases, Negros Oriental reports doubling of cases
- Monkeypox mean incubation period estimated at 8.5 days: Netherlands study
- Scabies outbreak affects more than 1000 in Hoima district, Uganda
- H5N6 avian influenza case reported in Jiangxi province, China
- Monkeypox in Africa: 1,715 cases, 73 deaths in 2022 to date, according to African CDC